STORM Therapeutics Limited Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
STORM Therapeutics Limited is a UK-based biotechnology company focused on discovering and developing therapies that inhibit RNA modifying enzymes, with the aim of treating oncology and other diseases. The firm operates from Babraham, near Cambridge, and has established an in-house research program complemented by collaborations with contract research organizations to maintain a cost-efficient development pathway. Its work is grounded in the observation that numerous RNA modifications and modifying enzymes present potential therapeutic targets, and it pursues a pipeline of first-in-class small-molecule candidates targeting these enzymes. The lead program centers on a METTL3 inhibitor, STC-15, which has progressed to an IND filing and early clinical evaluation, indicating the company’s progression toward clinical testing in cancer patients; additional candidates are planned for IND-track activities. In recent developments, STORM has engaged in partnerships and attended major scientific forums to present data from its ongoing Phase 1 studies and related early-stage programs.